Sichuan Hebang Biotechnology Corporation Limited (SHA: 603077)

Sichuan Hebang Biotechnology Corporation Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	15,810	20,591	26,524	28,624	12,117	12,737
Market Cap Growth	-17.13%	-22.37%	-7.33%	136.22%	-4.87%	-10.97%
Enterprise Value	17,300	19,320	24,994	28,461	13,894	13,762
Last Close Price	1.97	2.34	2.96	3.30	1.37	1.43
PE Ratio	33.90	16.05	6.97	9.48	295.96	24.64
Forward PE	-	14.96	14.96	14.96	14.96	14.96
PS Ratio	1.79	2.33	2.03	2.87	2.30	2.13
PB Ratio	0.84	1.02	1.34	1.96	1.07	1.11
P/TBV Ratio	1.15	1.33	1.75	2.76	1.47	1.55
P/FCF Ratio	-	-	15.53	19.58	70.55	-
P/OCF Ratio	-	256.33	10.03	8.75	32.85	78.18
EV/Sales Ratio	1.88	2.19	1.92	2.85	2.64	2.31
EV/EBITDA Ratio	10.66	8.02	4.63	6.65	11.92	10.76
EV/EBIT Ratio	30.60	13.59	5.57	7.80	26.59	21.40
EV/FCF Ratio	-18.55	-	14.63	19.47	80.89	-
Debt / Equity Ratio	0.18	0.10	0.09	0.09	0.19	0.16
Debt / EBITDA Ratio	2.12	0.81	0.34	0.32	1.84	1.45
Debt / FCF Ratio	-	-	1.06	0.94	12.48	-
Asset Turnover	0.36	0.36	0.62	0.61	0.36	0.43
Inventory Turnover	1.80	2.11	5.01	7.60	4.45	4.00
Quick Ratio	0.95	1.40	1.92	1.10	0.81	0.70
Current Ratio	1.88	2.69	2.60	1.49	1.05	1.25
Return on Equity (ROE)	2.31%	6.40%	22.15%	23.33%	0.03%	4.47%
Return on Assets (ROA)	1.39%	3.65%	13.34%	13.97%	2.23%	2.90%
Return on Capital (ROIC)	1.56%	4.06%	14.92%	15.49%	2.44%	3.13%
Earnings Yield	2.95%	6.23%	14.35%	10.55%	0.34%	4.06%
FCF Yield	-5.90%	-3.63%	6.44%	5.11%	1.42%	-3.92%
Dividend Yield	2.05%	-	1.52%	0.45%	-	-
Payout Ratio	17.19%	36.13%	5.20%	2.58%	226.52%	13.76%
Buyback Yield / Dilution	4.23%	-0.10%	-3.10%	1.10%	1.48%	4.62%
Total Shareholder Return	6.28%	-0.10%	-1.57%	1.55%	1.48%	4.62%

Source: S&P Capital IQ. Standard template. Financial Sources.